Nachrichten zur Pfizer Inc. Aktie

Duff & de la Cruz: Pfizer’s $650 Million Groton Investment Is a Bet on Connecticut

Duff & de la Cruz: Pfizers $650 Million Groton Investment Is a Bet on Connecticut "Pfizer could have built this…

Pfizer Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Pfizer nach Zahlen von 27 auf 30 US-Dollar…

+++ Geschäftszahlen +++: Ferrari übertrifft die Erwartungen – starker Gewinnsprung bei Intesa

Server-Hersteller SMCI mit Rekord-Quartalsumsatz +++ Biontech schreibt wieder schwarze Zahlen und stockt Umsatzziel auf +++ +++ Auch Pfizer verbucht ein…

Pfizer hikes full-year outlook on new product growth, taps company veteran as new CFO

Pfizer announced that Cecile Guegan, who has held various leadership roles at the company over the last 20 years, stepped…

Pfizer Aktie: Pharmakonzern gibt Geschäftszahlen bekannt - Aktienkurse nahe Mehrjahreshochs

Pfizer übertrifft die Erwartungen und hebt die Jahresprognose an – neue Medikamente stärken die Wachstumsperspektiven.…

Pfizer Aktie: Solide Zahlen, angehobene Prognose

Umsatz und Gewinn leicht rückläufig, aber über Erwartungen…

Pfizer (PFE) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Pfizer (PFE) give a sense of how its business performed in the quarter ended…

Pfizer hebt nach überraschend robustem Quartal die Jahresziele an

NEW YORK (dpa-AFX) Der US-amerikanische Pharmamulti Pfizer bessert nach einem unerwartet guten Quartal noch einmal…

Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more

These are the stocks posting the largest moves premarket.…

Pfizer Aktie vor Q3 2026 Zahlen: 36 oder 25 USD? Analysten-Kursziele und Ratings

Die Pfizer Aktie steht vor den Quartalszahlen am 3. November im Fokus: Welche Analysten behalten recht?…

Pfizer (PFE) Stock Sinks As Market Gains: Heres Why

Pfizer (PFE) closed at $29.45 in the latest trading session, marking a -1.17% move from the prior day.…

What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer

They definitely matter... up to a point.…

Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, Pfizer (PFE) closed at $30.11, marking a +2.28% move from the previous day.…

Pfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe?

Pfizers dividend yield is attractive, but investors need to know if it can maintain it.…

Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?

Pfizer Inc. (NYSE:PFE) trades at a considerable discount to AbbVie Inc. (NYSE:ABBV), despite both companies reporting growth in important parts…

2 High-Yield Dividend Stocks Worth Buying Before 2026 Ends

Verizon and Pfizer pay generous dividends, and each has a different path to growth. Heres how income investors can lock…

Pfizer (PFE) Gains As Market Dips: What You Should Know

The latest trading day saw Pfizer (PFE) settling at $29.21, representing a +2.96% change from its previous close.…

Pfizer Aktie vor Q3-Zahlen: BofA erhöht Kursziel auf 29 USD - wie viel Potenzial bleibt?

Bad Marienberg (www.aktiencheck.de) - Höheres Kursziel, unverändert vorsichtiges Urteil: In der Pfizer-Aktienanalyse vom 09.10.2026 hebt BofA-Analyst Jason Gerberry das Kursziel…

How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?

Youll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and…

How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?

Youll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and…

Cancer Stocks to Consider as Oncology Innovation Accelerates

Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and…

JPMorgan hebt Ziel für Pfizer auf 30 Dollar - Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Pfizer von 28 auf 30 US-Dollar angehoben, aber…

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Pfizers Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results

PFEs oncology growth in Q3 hinges on key drug sales, biosimilars and progress across a late-stage pipeline.…

Pfizer to cut around 330 jobs in Italy, unions say

Pfizer to cut around 330 jobs in Italy, unions say…

Pfizer vs. J&J: Comparing Growth, Patent Risks and Valuation

J&Js diversified portfolio, new drug launches and sales growth give it an edge despite Pfizers cheaper valuation and higher yield.…

Notable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus

…

Pfizer Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer von 34 auf 35 US-Dollar angehoben und…

Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

Pfizer (PFE) closed the most recent trading day at $28.1, moving 1.47% from the previous trading session.…

Florida sues Pfizer over Covid-19 vaccine safety claims

Florida sues Pfizer over Covid-19 vaccine safety claims…

Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims

Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims…

Novo vs. Pfizer: Which Large Drugmaker Offers Better Growth Prospects?

NVO and PFE offer different growth paths, with diversified portfolios, pipelines and near-term challenges shaping their outlooks.…

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could…

Pfizer: Buy Before The Street Catches Up To Its Own Numbers

…

AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?

AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and…

Pfizer: Poised For Gains With A New Drug Pipeline And Cost-Cutting Plans

…

Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick?

AbbVie and Pfizer are reshaping their growth strategies as new drugs, acquisitions, pipelines and patent challenges shape their outlooks.…

Pfizer Inc. (PFE) Presents at U.S. All Stars Conference Transcript

…

Pfizer: The Market Wont Pay For 2029 Until It Can - Downgrading To Hold

…

AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?

These companies are committed to rewarding shareholders.…

Pfizer Says Its Biggest Headwinds Are Finally Easing. Does That Change the Story for This Ultra-High-Yield Dividend Stock?

Pfizers rebound is well underway.…

dpa-AFX ProFeed